Under construction – not a live service

Skip to content

Frontlight Research

Institution

Montefiore Medical Center

Bronx, United StateshealthcareWebsite

Also known as: MMC

412running trials
160closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Not yet recruiting
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
NCT06510296· Source
Recruiting
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
NCT07615049· Phase 3· Source
Recruiting
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
NCT07310420· Phase 1· Source
Recruiting
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
NCT07293247· Phase 2· Source
Recruiting
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
NCT07920484· Source
Not yet recruiting
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
NCT06458907· Source
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
NCT06917911· Phase 2· Source
Not yet recruiting
The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2
NCT07146230· Phase 2· Source
Recruiting
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
NCT07527299· Source
Recruiting
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
NCT07022678· Phase 3· Source
Recruiting
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
NCT07441681· Phase 3· Source
Recruiting
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
NCT07228052· Phase 4· Source
Recruiting
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
NCT07452458· Phase 3· Source
Recruiting
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
NCT07725380· Phase 1/2· Source
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
NCT07466316· Phase 3· Source
Recruiting
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
NCT07559903· Source
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
NCT07581002· Phase 2/3· Source
Recruiting
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
NCT07671911· Phase 3· Source
Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
NCT07504458· Phase 3· Source
Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
NCT07563881· Phase 3· Source
Recruiting
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
NCT07429266· Phase 3· Source
Recruiting
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
NCT07296744· Source
Recruiting
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
NCT07326566· Phase 2· Source
Recruiting
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
NCT07298473· Source
Recruiting
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
NCT07523750· Source
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
NCT07200830· Phase 3· Source
Recruiting
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
NCT07335510· Source
Recruiting
Continuous Dual Aspiration Technique With Zoom System for Stroke
NCT07491952· Source
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849· Phase 3· Source
Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
NCT07166406· Phase 3· Source
Recruiting
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
NCT07194044· Phase 1· Source
Recruiting
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
NCT07283094· Phase 1· Source
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
NCT07198074· Phase 3· Source
Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07219212· Phase 1· Source
Recruiting
Digoxin Medulloblastoma Study
NCT06701812· Phase 2· Source
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946· Phase 3· Source
Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
NCT06686771· Phase 3· Source
Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
NCT07276399· Phase 3· Source
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146· Phase 3· Source
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027· Phase 2· Source
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
NCT07061977· Phase 3· Source
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
NCT07173751· Phase 3· Source
Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT07227532· Source
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07184996· Phase 3· Source
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
NCT07207811· Phase 3· Source
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184931· Phase 3· Source
Active, not recruiting
SPHERE Per-AF Post-Approval Study
NCT06858306· Source
Recruiting
ASTHMAXcel Voice Study
NCT06935084· Source
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
NCT06958328· Phase 3· Source
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Childhood cancers37 recruiting
Lung cancer21 recruiting
Acute myeloid leukemia18 recruiting
Prostate cancer12 recruiting
Sarcoma12 recruiting
Head and neck cancer9 recruiting
Myelodysplastic syndromes9 recruiting
Stroke9 recruiting
Coronary artery disease8 recruiting
Acute lymphoblastic leukaemia7 recruiting
Atrial fibrillation7 recruiting
Heart failure6 recruiting
Metastatic breast cancer5 recruiting
Myeloproliferative neoplasms5 recruiting
Bladder cancer4 recruiting
Chronic myeloid leukaemia4 recruiting
Colorectal cancer4 recruiting
HIV4 recruiting
Ovarian cancer4 recruiting
Asthma3 recruiting
Diffuse large B-cell lymphoma3 recruiting
Follicular lymphoma3 recruiting
Gastric and esophageal cancer3 recruiting
Idiopathic pulmonary fibrosis3 recruiting
Kidney cancer3 recruiting
Liver and biliary tract cancer3 recruiting
Multiple myeloma3 recruiting
Sickle cell disease3 recruiting
Triple-negative breast cancer3 recruiting
Chronic kidney disease2 recruiting
Chronic lymphocytic leukaemia2 recruiting
Crohn's disease2 recruiting
Endometrial cancer2 recruiting
Epilepsy2 recruiting
Glioblastoma2 recruiting
Lupus (SLE)2 recruiting
Melanoma2 recruiting
Migraine2 recruiting
Neuroblastoma2 recruiting
Neuroendocrine tumours2 recruiting
Osteoporosis2 recruiting
Pancreatic cancer2 recruiting
Ulcerative colitis2 recruiting
Amyloidosis1 recruiting
ANCA-associated vasculitis1 recruiting
Atopic dermatitis (eczema)1 recruiting
Cervical cancer1 recruiting
Duchenne muscular dystrophy1 recruiting
Glaucoma1 recruiting
Haemophilia1 recruiting
High blood pressure1 recruiting
Hodgkin lymphoma1 recruiting
Mantle cell lymphoma1 recruiting
Pulmonary arterial hypertension1 recruiting
Systemic sclerosis (scleroderma)1 recruiting
Thalassaemia1 recruiting
Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

Terminated
Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy
NCT06775886· Source
Completed
Data Collection for Echocardiography-Based Software Assessment
NCT07126600· Source
Completed
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
NCT06604442· Phase 4· Source
Terminated
A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies
NCT06508489· Phase 1/2· Source
Completed
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC
NCT06366451· Early phase 1· Source
Completed
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
NCT06331624· Phase 2· Source
Completed
RECOVER-AUTONOMIC Platform Protocol
NCT06305780· Phase 2· Source
Withdrawn
Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations
NCT05807126· Phase 1· Source
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877· Phase 3· Source
Completed
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
NCT06181435· Phase 3· Source
Completed
A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF
NCT06144632· Source
Terminated
A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382
NCT06032546· Phase 2· Source
Completed
HEAL-LAA Clinical Trial
NCT05809596· Source
Terminated
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
NCT06026332· Source
Completed
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
NCT05776225· Source
Completed
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
NCT05510908· Source
Completed
Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors
NCT05775406· Phase 1· Source
Completed
Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.
NCT05630001· Phase 3· Source
Completed
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05704738· Phase 3· Source
Completed
Sphenopalatine Ganglion Block Study
NCT05707754· Phase 1· Source
Completed
NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial
NCT05666713· Source
Completed
Hospital Airway Resuscitation Trial
NCT05520762· Source
Completed
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
NCT05651711· Phase 3· Source
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT05633654· Phase 3· Source
Terminated
Study of the ZN-d5 and ZN-c3 in Subjects With Acute Myeloid Leukemia (AML)
NCT05682170· Phase 1/2· Source
Completed
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT05601882· Phase 3· Source
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
NCT05614063· Phase 3· Source
Completed
Multicultural Healthy Diet in Chronic Kidney Disease
NCT05504850· Source
Completed
Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
NCT05509400· Phase 4· Source
Completed
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
NCT05525520· Phase 2· Source
Completed
Testing Two Models of PrEP Delivery in OBGYN Clinics
NCT05015855· Source
Withdrawn
ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
NCT05481905· Phase 2· Source
Completed
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
NCT05083182· Phase 3· Source
Terminated
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer
NCT05353439· Phase 1· Source
Completed
Research Study Investigating How Well NDec Works in People With Sickle Cell Disease
NCT05405114· Phase 2· Source
Completed
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT04919512· Phase 2· Source
Completed
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
NCT05452239· Phase 4· Source
Completed
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
NCT05360680· Phase 1· Source
Completed
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
NCT05077709· Phase 2· Source
Terminated
A Study to Investigate LYL797 in Adults With Solid Tumors
NCT05274451· Phase 1· Source
Completed
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
NCT05217927· Phase 4· Source
Terminated
Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD
NCT04930445· Source
Completed
Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
NCT05104853· Phase 1/2· Source
Completed
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer
NCT04600336· Phase 2· Source
Completed
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT05005728· Phase 2· Source
Completed
The Effects of Music and Television on Intraoperative Hypertensive Events in Cataract Surgery
NCT06356324· Source
Completed
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
NCT04129125· Source
Completed
To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)
NCT04894591· Source
Terminated
Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab
NCT04887831· Phase 2· Source
Completed
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT04708782· Phase 3· Source

Trial sites

Conditions

Diseases this institution publishes on or runs trials for.

Stroke138 works · 18 trials
Heart failure122 works · 19 trials
Atrial fibrillation71 works · 20 trials
Coronary artery disease43 works · 17 trials
Migraine31 works · 9 trials
Acute myeloid leukemia22 works · 35 trials
Endometrial cancer15 works · 12 trials
Sickle cell disease10 works · 11 trials
Myelodysplastic syndromes8 works · 16 trials
ANCA-associated vasculitis3 works · 1 trials

Institution data: ROR 044ntvm43 (CC0-1.0)Updated 10 Nov 2026

Report an error